The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-isopropyl-N-(2-(isoxazol-3-ylamino)-2-oxoethyl)-2-(4-propylphenoxy)acetamide ID: ALA4547025
PubChem CID: 155552542
Max Phase: Preclinical
Molecular Formula: C19H25N3O4
Molecular Weight: 359.43
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCCc1ccc(OCC(=O)N(CC(=O)Nc2ccon2)C(C)C)cc1
Standard InChI: InChI=1S/C19H25N3O4/c1-4-5-15-6-8-16(9-7-15)25-13-19(24)22(14(2)3)12-18(23)20-17-10-11-26-21-17/h6-11,14H,4-5,12-13H2,1-3H3,(H,20,21,23)
Standard InChI Key: HQSWSDWYNGRIOF-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 27 0 0 0 0 0 0 0 0999 V2000
24.7908 -2.5382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7897 -3.3577 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4977 -3.7667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2074 -3.3573 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2046 -2.5346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4960 -2.1293 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0817 -3.7658 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0810 -4.5830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3730 -4.9910 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9107 -2.1234 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.6200 -2.5293 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3261 -2.1180 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0354 -2.5239 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.3231 -1.3008 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.0385 -3.3411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7416 -2.1127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4508 -2.5186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3323 -3.7524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7477 -3.7471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4539 -3.3358 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.1570 -2.1073 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.8662 -2.5133 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9585 -3.3208 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.7585 -3.4877 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.1644 -2.7784 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6152 -2.1733 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
2 7 1 0
7 8 1 0
8 9 1 0
5 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
12 14 2 0
13 15 1 0
13 16 1 0
16 17 1 0
15 18 1 0
15 19 1 0
17 20 2 0
17 21 1 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 1 0
25 26 2 0
26 22 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 359.43Molecular Weight (Monoisotopic): 359.1845AlogP: 2.88#Rotatable Bonds: 9Polar Surface Area: 84.67Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.84CX Basic pKa: ┄CX LogP: 2.98CX LogD: 2.97Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.74Np Likeness Score: -1.82
References 1. Yu J, Xu L, Hong D, Zhang X, Liu J, Li D, Li J, Zhou Y, Liu T.. (2019) Design, synthesis, and biological evaluation of novel phenol ether derivatives as non-covalent proteasome inhibitors., 161 [PMID:30391816 ] [10.1016/j.ejmech.2018.10.056 ]